Impact News +++ Why Rezolve AI Stock Rocketed Higher Today (Fool) +++ REZOLVE AI Aktie -4,29%

PENUMBRA Aktie

>PENUMBRA Aktienkurs

278 EUR (TradegateBSX)

Ask: 279 EUR / 35 Stück

Bid: 277 EUR / 36 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

PENUMBRA Aktie über LYNX handeln

Intraday

1 Jahr

>PENUMBRA Performance

1 Woche: -1,0%

1 Monat: -0,8%

3 Monate: -2,5%

6 Monate: -3,1%

1 Jahr: +22,5%

laufendes Jahr: +2,8%

>PENUMBRA Aktie

Profil:

Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the company operates within the specialized field of int..
>Volltext..

Insiderhandel:

>PENUMBRA Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>PENUMBRA Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Neurologische Erkrankungen/ Schlaganfälle

>PENUMBRA Chart & Kurs - NYSE

>PENUMBRA News

30.07.26 - 22:06	Penumbra, Inc. Reports Second Quarter 2026 Financial Results (PR Newswire)
	ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026. Revenue of $390.0 million in the second quarter of 2026, an increase of 14.9% compared to the......

22.07.26 - 20:39	THUNDER Study Demonstrates Penumbra′s THUNDERBOLT is Safe and Effective for Stroke Care (PR Newswire)
	First and only CAVT device for stroke demonstrated high revascularization rates, short procedure times and low complication rates ALAMEDA, Calif., July 22, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the results of THUNDER, an......

07.07.26 - 15:03	First Patient Enrolled in Penumbra′s FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke (PR Newswire)
	ALAMEDA, Calif., July 7, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical......

06.07.26 - 14:03	GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT (GlobeNewswire EN)
	Leading Vascular Specialist and Penumbra Chief Medical Officer Joins GuideAI to Help Advance Its Recently FDA-Cleared VAOT Triage Software Leading Vascular Specialist and Penumbra Chief Medical Officer Joins GuideAI to Help Advance Its Recently FDA-Cleared VAOT Triage Software...

18.06.26 - 20:30	Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain? (Zacks)
	PEN gains CE Mark in Europe for THUNDERBOLT, expanding stroke treatment access and advancing its global stroke care strategy....

11.06.26 - 22:09	Penumbra′s THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke (PR Newswire)
	THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal ALAMEDA, Calif., June 11, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced it has received U.S.......

07.05.26 - 01:00	Penumbra (PEN) Misses Q1 Earnings Estimates (Zacks)
	Penumbra (PEN) delivered earnings and revenue surprises of -25.91% and +1.35%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...

06.05.26 - 23:33	Penumbra GAAP EPS of $0.82 misses by $0.26, revenue of $374.8M beats by $2.76M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.05.26 - 22:09	Penumbra, Inc. Reports First Quarter 2026 Financial Results (PR Newswire)
	ALAMEDA, Calif., May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026. Revenue of $374.8 million in the first quarter of 2026, an increase of 15.6% compared to the......

27.04.26 - 20:30	3 Reasons Why Penumbra (PEN) Is a Great Growth Stock (Zacks)
	Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials....

19.04.26 - 16:45	Boston Scientific: Warum der Kurssturz nach der Penumbra-Übernahme eine Einstiegschance ist (Tim Schaefer)
	Die Wall Street ist extrem kurzsichtig. Sobald eine kleine Wolke am Horizont auftaucht, werfen nervöse Anleger ihre Papiere… Der Beitrag Boston Scientific: Warum der Kurssturz nach der Penumbra-Übernahme eine Einstiegschance ist erschien zuerst auf Tim Schäfer Media....

10.04.26 - 20:30	3 Reasons Why Growth Investors Shouldn′t Overlook Penumbra (PEN) (Zacks)
	Penumbra (PEN) could produce exceptional returns because of its solid growth attributes....

07.04.26 - 22:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Penumbra im Wert von 32822 USD (Insiderkauf)
	Grewal, Harpreet - Aufsichtsrat - Tag der Transaktion: 2026-04-02...

27.03.26 - 18:00	Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound? (Zacks)
	Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

17.03.26 - 19:30	Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
	Penumbra (PEN) could produce exceptional returns because of its solid growth attributes....

05.03.26 - 07:01	Insiderhandel: Chief Financial Officer verkauft Aktien von Penumbra im Wert von 832474 USD (Insiderkauf)
	Yuen, Maggie - Vorstand - Tag der Transaktion: 2026-03-02...

02.03.26 - 15:01	PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
	Penumbra jumps after Q4 earnings and revenue beat, with double-digit sales growth, margin expansion and strong U.S. performance across key product lines....

26.02.26 - 00:15	Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics (Zacks)
	While the top- and bottom-line numbers for Penumbra (PEN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

25.02.26 - 23:30	Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
	Penumbra (PEN) delivered earnings and revenue surprises of +5.36% and +6.74%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

25.02.26 - 19:36	XFRA: ZERTIFIKATEBOERSE RESUMPTION OF UNDERL.: US70975L1070 (XETRA)
	ALLE STRUKTURIERTEN PRODUKTE MIT UNDERLYING US70975L1070 SIND AB 19:27 CET WIEDER IN DEN HANDEL AUFGENOMMEN. ALL STRUCTURED PRODUCTS WITH UNDERLYING US70975L1070 ARE RESUMED TRADING FROM ONWARDS 19:27 CET....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die Frucht eines Luxuslebens ist Luxus. - Henry David Thoreau

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram